-
Biogen Inc. (BIIB $143.32)
-
Intuitive Surgical Inc. (ISRG $433.99)
-
AbbVie Inc. (ABBV $217.61)
-
Eli Lilly and Company (LLY $748.19)
-
Repligen Corporation (RGEN $113.74)
Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward. Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space. Thanks kindly for your thoughts.